El comportamiento del factor de necrosis tumoral alfa e interleucina 6 en lesiones de vías biliares postcolecistectomía / Tumor necrosis factor-alpha and interleukin-6 levels among patients suffering a bile duct injury during cholecystectomy
Rev. méd. Chile
;
138(10): 1259-1263, oct. 2010. graf
Article
Dans Espagnol
| LILACS
| ID: lil-572937
ABSTRACT
Background:
During cholecystectomy, the bile duct may be injured. When this complication occurs, Kupffer cells are activated and produce tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL6) to phagocyte toxic productsAim:
To measure serum levels of TNF-α and IL-6 among patients that suffered a bile duct injury after a cholecystectomy. Patients andMethods:
Serum levels of TNF-α and IL-6 were measured prior to the bile-enteric derivation and after one year of follow up, in 31 patients that had a complete bile duct obstruction after open or laparoscopic cholecystectomy and in 5 healthy controls.Results:
At baseline TNF-α levels in healthy subjects and patients with bile duct injury were 0 and 43.9 ± 2.9 ng/mL, respectively (p < 0.01). At one year of follow up, TNF-á became undetectable among patients. At baseline, the values for IL-6 among healthy controls and patients were 3.0 ± 2.0 and 72.0 ± 94.7 pg/mL respectively, (p < 0,004). After one year of follow up, IL-6 levels decreased to 6.4 ± 0.3 pg/mL among patients.Conclusions:
TNF-α and IL-6 levels were elevated before bile-enteric derivation among patients with bile duct injury and became normal one year later.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Conduits biliaires
/
Cholestase
/
Facteur de nécrose tumorale alpha
/
Cholécystectomie laparoscopique
/
Cellules de Küpffer
Type d'étude:
Étude observationnelle
/
Étude de prévalence
/
Facteurs de risque
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2010
Type:
Article
/
descriptif de projet
Pays d'affiliation:
Mexique
Institution/Pays d'affiliation:
Universidad de Guadalajara/MX
/
instituto Mexicano del seguro social/MX
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS